Interestingly, Zhou et al. demonstrated that combination therapy with disulfiram/Cu2+ and an anti-PD-1 antibody showed much better antitumor efficacy than monotherapy via PD-L1 stabilization in hepatocellular carcinoma [32]. Here, CD274 is linked to hepatocellular carcinoma.